170
Participants
Start Date
April 18, 2024
Primary Completion Date
February 28, 2026
Study Completion Date
February 28, 2026
University of Alabama at Birmingham - Main /ID# 260000, Birmingham
North Star Medical Research LL /ID# 259730, Middleburg Heights
Rivus Wellness And Research Institute /ID# 259966, Oklahoma City
Bowman Medical Group /ID# 259989, Beverly Hills
UC Davis /ID# 259723, Sacramento
Montano Wellness LLC /ID# 259837, Cromwell
Georgia Psychiatric Consultants & Advanced Discovery Research /ID# 259975, Atlanta
Omaha Insomnia and Psychiatric Services /ID# 259961, Omaha
Quest Therapeutics of Avon /ID# 259838, Avon Lake
Betts Psychiatric, PC /ID# 259737, Eugene
Ut Southwestern Medical Center /Parkland Health and Hospital System /Id# 260001, Dallas
Chatham-Kent Clinical Trials /ID# 262414, Chatham
Grand River Hospital /ID# 263962, Kitchener
Sunny Johnson Medical Research Associates /ID# 267713, Mississauga
Southlake Regional Health Centre /ID# 264212, Newmarket
START Clinic for Mood and Anxiety Disorders /ID# 262416, Toronto
Institut universitaire en santé mentale de Montréal /ID# 264665, Montreal
Clinique Woodward /ID# 264050, Sherbrooke
Douglas Mental Health University Institute /ID# 262048, Verdun
Lead Sponsor
AbbVie
INDUSTRY